2 completed, 1 unknown, 1 withdrawn. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Unknown 1, Withdrawn 1 |
Follow Valchlor: new trials by email Literature Review of Valchlor trials Research Report on Valchlor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL Hypericin, Mechlorethamine Topical Gel - Cutaneous T-Cell Lymphoma/Mycosis Fungoides | Phase 2 | Completed | Soligenix | 10 | 2023-12-05 | 2025-08-20 |
| Low Dose Total Skin Electron Beam Radiation Therapy and Mechlorethamine Hydrochloride Gel in Treating Patients With Mycosis Fungoides Mechlorethamine Hydrochloride Gel, Total Skin Electron Beam Radiation Therapy - Mycosis Fungoides | Phase 2 | Withdrawn | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2018-08-01 | 2025-04-29 | |
| Valchlor in the Treatment of Lichen Planopilaris Mechlorethamine 0.016% Top Gel - Lichen Planopilaris | Phase 2 | Completed | Mayo Clinic | 12 | 2018-04-01 | 2021-01-28 |
| Low Dose Total Skin Electron Beam Treatment (TSEBT) Followed by Maintenance Valchlor for Patients With Mycosis Fungoides Total skin electron beam therapy (TSEBT), mechlorethamine gel 0.016% - Mycosis Fungoides, Cutaneous T-cell Lymphoma | Phase 2 | Unknown | Thomas Jefferson University | 68 | 2016-09-01 | 2016-08-30 |
Mycosis Fungoides (3) · Lichen Planus (1) · Lymphoma, T-Cell, Cutaneous (1)
Mayo Clinic (1) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1) · Soligenix (1) · Thomas Jefferson University (1)
United States (3)
Jason Sluzevich, MD (1) · Joya Sahu, MD (1)